We are live on
!
Find out more
NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$43M
1-Year Est. Return
25.55%
This Fund
S&P 500
This Quarter
Est. Return
+8.17%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$116M
AUM Growth
-$4.58M
(-3.8%)
Cap. Flow
-$8.42M
Cap. Flow
% of AUM
-7.23%
Top 10 Holdings %
Top 10 Hldgs %
96.58%
Holding
17
New
–
Increased
–
Reduced
–
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
+$6.56M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
+$1.54M |
| 3 |
TECX
Tectonic Therapeutic
TECX
|
+$316K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BAM
MAM
WCPI
WAMC
CC
CIEP
IPI
VSAM
New Leaf Venture Partners's Q2 2023 Portfolio in Review
As of Q2 2023, New Leaf Venture Partners held 17 positions worth $116M, down 3.8% from $121M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
New Leaf Venture Partners withdrew a net $8.42M in Q2 2023, closing 3 positions. Its most notable exit was Amryt Pharma plc American Depositary Shares, an estimated $6.56M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- New Leaf Venture Partners fully exited Amryt Pharma plc American Depositary Shares in Q2 2023, selling an estimated $6.56M.
- New Leaf Venture Partners's ten largest holdings make up 97% of its $116M portfolio in Q2 2023.
- New Leaf Venture Partners opened 0 new positions and closed 3 in Q2 2023.
- New Leaf Venture Partners's portfolio value fell 3.8% quarter-over-quarter to $116M.
Based on New Leaf Venture Partners's 13F filing for Q2 2023, filed 10 Aug 2023.